Hear a Critical Update from our Executive Director and learn more about WHY and HOW we Walk Strong Together. Featuring Cure JM Executive Director, Jim Minow, Director of Development and Community Engagement, Shannon Malloy, Board Member and Southern California Walk Chair, Zack Harrison, and Chapter & Walk Manager, Nicole Ryba.
Vamorolone FAQs in JM
With the looming FDA approval of the drug vamorolone in Duchenne muscular dystrophy, there are questions surrounding the drug’s status for trials in juvenile myositis. We have consulted with JM experts on the potential implications of a pending approval for the drug in another disease and what this currently means for JM patients living in the U.S.
